跳至主要内容
临床试验/CTRI/2015/05/005741
CTRI/2015/05/005741已完成4 期

A Post Marketing Surveillance study of Recombinant Insulin Glargine (Basugineâ?¢) in the management/treatment of adult patients with type I or type II Diabetes Mellitus in daily medical practice - Post Marketing Surveillance Study

G Life Sciences India Pvt Ltd0 个研究点目标入组 300 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
300

研究概览

简要总结

暂无简介。

研究设计

研究类型
Pms

入排标准

入选标准

  • Adult patients with type I or type II diabetes mellitus who require
  • basal (long acting) insulin for the control of hyperglycemia according
  • to the clinical judgement of the physician.
  • Willing and able to give informed consent.

排除标准

  • Contraindication - hypersensitivity to the active substance or to any
  • of the excipients as mentioned in the local prescribing information

研究者

发起方
G Life Sciences India Pvt Ltd

相似试验